1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Sjogren’s syndrome - Epidemiology Forecast - 2030

Sjogren’s syndrome - Epidemiology Forecast - 2030

  • September 2020
  • 100 pages
  • ID: 5962314
  • Format: PDF
  • Delve Insight


Table of Contents

‘Sjogren’s syndrome (SS)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Sjogren’s syndrome, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Sjogren’s syndrome (SS) Disease Understanding
Sjogren’s syndrome (SS) is a chronic autoimmune disease with a specific predisposition for causing inflammation of the exocrine glands, predominantly the salivary and lacrimal glands but also including the nose, upper respiratory tract, and oropharynx and, in women, the vagina. In this, the immune system inappropriately attacks various cells that leads to activation of the various pathway, which results in inflammation. The main consequence of this inflammation is the development of sicca symptoms due to damage to salivary and tear glands, such as dryness of the mucosal surfaces, principally in the mouth and eyes. Increased levels of cytokines and chemokines and autoantibodies expressed by the epithelium of the exocrine glands (such as the salivary and lacrimal glands) lead to chronic inflammation and the eventual loss of their physiological functions.
Due to the wide variety of signs and symptoms, patients with Sjögren’s syndrome may see a diverse range of healthcare practitioners, including family physicians, ophthalmologists, ENT specialists, and dentists, at the first consultation. Thus, physicians of various specialties must be informed about current aspects of clinical manifestations of the disease, the revised classification criteria, and current treatment options.

Sjogren’s syndrome (SS) Epidemiology
The Sjogren’s syndrome epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings
The disease epidemiology covered in the report provides historical as well as forecasted Sjogren’s syndrome epidemiology segmented as the Diagnosed Prevalent Cases of Sjögren’s syndrome, Gender-Specific Cases of Sjögren’s syndrome, Type-Specific Cases of Sjögren’s syndrome, Severity-Specific Cases of Sjögren’s syndrome. The report includes the Prevalent scenario of Sjogren’s syndrome symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2030.

Country Wise- Sjogren’s syndrome (SS) Epidemiology
The epidemiology segment also provides the Sjogren’s syndrome (SS) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
The total prevalent population of Sjogren’s syndrome in 7MM countries was estimated to be 3,179,223 cases in 2017.
• As per the estimates, the United States has the highest Prevalent population of Sjogren’s syndrome
• Among the EU5 countries, the UK had the highest Prevalent population of Sjogren’s syndrome. On the other hand, Spain had the lowest Prevalent population with 197,008 cases in 2017.

Scope of the Report
• Sjogren’s syndrome (SS) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• Sjogren’s syndrome (SS) Epidemiology Report and Model provide an overview of the risk factors and global trends of Sjogren’s syndrome (SS) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight about the historical and forecasted patient pool of Sjogren’s syndrome (SS) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) and Japan
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Sjogren’s syndrome
• The report provides the segmentation of the Sjogren’s syndrome (SS) epidemiology by Prevalent Cases of Sjogren’s syndrome (SS) in 7MM
• The report provides the segmentation of the Sjogren’s syndrome (SS) epidemiology by Type–specific, Gender–specific and Severity–specific Prevalent Cases of Sjogren’s syndrome (SS) in 7MM

Report Highlights

• 11-Year Forecast of Sjogren’s syndrome (SS) epidemiology
• 7MM Coverage
• Total Prevalent Cases of Sjogren’s syndrome (SS)
• Prevalent Cases according to segmentation: Type-specific Prevalence of Sjogren’s syndrome (SS), Gender-specific Prevalenceof Sjogren’s syndrome (SS), Severity-specific Prevalenceof Sjogren’s syndrome (SS)
KOL- Views
We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered
• What will be the growth opportunities in the 7MM concerning the patient population about Sjogren’s syndrome (SS)?
• What are the key findings pertaining to Sjogren’s syndrome (SS) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017–2030)?
• What would be the total number of patients of Sjogren’s syndrome (SS) across the 7MM during the forecast period (2017–2030)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017–2030)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017–2030)?
• What are the disease risk, burden, and unmet needs of Sjogren’s syndrome?
• What are the currently available treatments for Sjogren’s syndrome?

Reasons to buy
The Sjogren’s syndrome (SS) Epidemiology report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the global Sjogren’s syndrome (SS) market
• Quantify patient populations in the global Sjogren’s syndrome (SS) market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Sjogren’s syndrome (SS) therapeutics in each of the markets covered
• Understand the magnitude of Sjogren’s syndrome (SS) population by its Prevalence cases
• Understand the magnitude of Sjogren’s syndrome (SS) population by its Etiology-specific cases
• The Sjogren’s syndrome (SS) epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
• The Sjogren’s syndrome (SS) Epidemiology Model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Study Period: 2017–2030
The study conducted by Maciel et al., (2017), titled “Prevalence of Primary Sjögren’s Syndrome in a Population-Based Cohort in the United States” is the first population-based study performed in the US and study reports the first prevalence trends of Sjögren’s syndrome.
A total of 106 patients with a physician-based diagnosis of pSS were living in 2015. Among these, 86% were female, with a mean age of 64.6 (15.2) years and disease duration of 10.5 (8.4) years. Most patients (98%) complained of dry mouth, dry eyes, or both.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Endometriosis - Epidemiology Forecast to 2030

  • $ 3995
  • December 2021
  • 44 pages

Endometriosis - Epidemiology Forecast to 2030 Summary Endometriosis is a common gynecological condition affecting women of reproductive ages.Women with endometriosis develop tissue that looks and acts ...

  • United States
  • Europe
  • Genitourinary System Disease
  • Epidemiology
  • Industry analysis
  • Prescription Drug Sales
  • Health Provider Density


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on